Since inflammation is the leading cause of COPD, and the TLR4/NF-kB signaling pathway mediates pulmonary inflammation, we used COPD model rats to explore the anti-inflammatory mechanisms of Feikang Granules. Here, TLR4 is linked to chronic obstructive pulmonary disease.